Skip to main content

Security report for igbamedicines.org

International Generic and Biosimilar medicines Association - IGBA · Healthcare · Spain

High risk. 9 critical or high findings in Network security, Security headers and 3 other checks.

Security score

43/100

Risk levelHigh

0–100, higher is better. How it is calculated

The International Generic and Biosimilar Medicines Association (IGBA) is a globally recognized industry association representing manufacturers and associations involved in generic and biosimilar medicines. Founded in 2015 and headquartered in Spain with operational presence in Geneva, Switzerland, IGBA focuses on advocacy, policy development, and promoting access to affordable, quality medicines worldwide. The website serves as a professional platform providing industry news, reports, events, and educational resources targeted at stakeholders in the pharmaceutical sector. Technically, the website is built on the Joomla CMS platform, utilizing JavaScript frameworks such as MooTools and jQuery, alongside third-party tools like Widgetkit and RokSprocket for enhanced UI components. The site is hosted by Hosting Concepts B.V. and employs HTTPS with a valid SSL certificate, ensuring secure communications. While the site demonstrates good mobile optimization and SEO practices, some technical debt is evident through the use of outdated JavaScript libraries, which could pose security risks. From a security perspective, the site enforces HTTPS and includes a cookie consent mechanism aligned with GDPR requirements. However, it lacks advanced security headers and does not publicly disclose a security policy or incident response contacts. DNSSEC is not enabled, and the presence of older JavaScript libraries suggests potential vulnerabilities. The WHOIS data is consistent and transparent, reinforcing the legitimacy of the domain and organization. Overall, IGBA's website is a credible and professional resource for the generic and biosimilar medicines industry, with a solid foundation in privacy compliance and business credibility. Security posture is moderate, with room for improvement in modernizing technical components and enhancing security policies. Strategic recommendations include updating libraries, enabling DNSSEC, implementing security headers, and publishing security and incident response information to strengthen trust and resilience.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

9 findings rated critical or high. Fix these first.

  1. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

Need hands-on remediation? Email guard@offseq.com

Keep watching igbamedicines.org

This scan found 30 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
15
Email security
70
DNS health
55
Network security
0
GDPR outside view
53
Average
43

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

IGBA occupies a strategic position as a global industry association advocating for generic and biosimilar medicines. Its business model centers on representing member organizations, influencing policy, and disseminating industry knowledge. The association targets pharmaceutical manufacturers, regulators, healthcare professionals, and policymakers. Revenue streams likely include membership fees, event sponsorships, and publication sales. The organization demonstrates growth through active event hosting and regular publication of reports and whitepapers. Partnerships with global health entities and participation in international forums enhance its influence and credibility. The website reflects a mature digital presence supporting these business objectives.

Security posture

The website exhibits a moderate security maturity level. HTTPS is properly implemented, and cookie consent mechanisms indicate awareness of privacy regulations. However, the absence of DNSSEC, lack of security headers, and use of outdated JavaScript libraries introduce potential vulnerabilities. No explicit security or incident response policies are published, which may hinder rapid response to security incidents. The domain registration is transparent and consistent, supporting trustworthiness. To elevate security posture, IGBA should modernize its technical stack, adopt DNSSEC, implement comprehensive security headers, and formalize security policies and incident response procedures.

Recommendations

  1. Enable DNSSEC on the domain to protect against DNS spoofing and improve domain security.
  2. Update all JavaScript libraries, especially jQuery, to the latest stable versions to mitigate known vulnerabilities.
  3. Implement security headers such as Content-Security-Policy, X-Content-Type-Options, X-Frame-Options, and Strict-Transport-Security to enhance browser security.
  4. Publish a clear security policy and provide incident response contact information to improve transparency and preparedness.
  5. Develop a long-term security strategy including regular vulnerability assessments, penetration testing, and staff security awareness training.

Contact details published on the site

Addresses
Legal name
International Generic and Biosimilar medicines Association - IGBA
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
International Generic and Biosimilar medicines Association - IGBA
Description
IGBA is an international network of generic and biosimilar medicines associations, promoting access to affordable generic and biosimilar medicines.
Key services
Advocacy for access to generic and biosimilar medicines, Industry representation, Publication of reports and whitepapers, Organizing events and conferences, Providing market data and policy statements
Content quality
good
Branding
consistent

Technology

Stack
Joomla CMS, MooTools JavaScript framework, jQuery 1.8.2, Widgetkit, RokSprocket, Google Analytics, LinkedIn Insight Tag
Frameworks
Joomla
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
70/100
Good practices seen
  • HTTPS enforced
  • ClientTransferProhibited domain status
  • Cookie consent banner implemented

Analytics and tracking

Services
Google Analytics, LinkedIn Insight
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
LinkedIn Insight
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and maintained using Joomla CMS.
  2. Content is focused on generic and biosimilar medicines industry advocacy and information.
  3. Active news updates and events indicate ongoing organizational activity.
  4. No signs of malicious or suspicious content.
  5. Cookie consent and privacy policy are implemented, indicating GDPR awareness.
  6. Some outdated JavaScript libraries present, which could pose security risks.
  7. No explicit security policy or incident response information published.
  8. No terms of service page found.
Technical notes

Notes

The website is built on Joomla CMS with additional UI components powered by Widgetkit and RokSprocket. It uses MooTools and an outdated version of jQuery (1.8.2), which is a technical debt and security risk. Hosting is provided by Hosting Concepts B.V. The site loads with moderate performance and is mobile optimized with responsive design elements. SEO is supported by proper meta tags and structured navigation. Accessibility is basic but could be improved. The presence of Google Analytics and LinkedIn Insight tags indicates moderate user tracking. Overall, the technical infrastructure is stable but would benefit from modernization and enhanced security configurations.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with igbamedicines.org. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review igbamedicines.org.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.